“Treatment of Moderate to Severe Glabellar Lines”
The objective of the study is to evaluate the efficacy and safety of a single dose of QM1114-DP compared to placebo for the treatment of moderate to severe GL.
Biological - botulinum toxin
neuromodulator to be injected in the GL region
Biological - Placebo
Placebo to be injected in the GL area
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines